Thursday 1 October

Location: Room S3

Topic 3: Advancements in Genetically Engineered Animal Models for Nonclinical Safety
08:00 - 08:30 | Sponsored Session: Airamatrix    
08:30 - 09:15 | Introductory talk on genetically engineered animal models - Roland Rad
09:15 - 09:50 | Genetically engineered mouse models in preclinical research: Challenges and considerations for pathologists - Sebastien Monette
09:50 - 10:10 | MALT1 Highlights the Complexity of Interpreting Engineered Mouse Models for Translational Immunology - Alessandro Piaia

10:10 - 10:55 | Morning Coffee Break - Exhibition area

10:55 - 11:25 | The practical advantages, disadvantages, and challenges of using GEMMs in Drug Discovery and Carcinogenicity Studies - Alys Bradley
11:25 - 11:50 | Humanized Mouse Models for Cell and Gene Therapy Safety: Power, Pitfalls, and the Pathologist’s Perspective - Giovanni Pelligrini
11:50 - 12:15 | Humanized Mouse Model for Nonclinical Safety Assessment of an Immunotherapeutic Monoclonal Antibody: Challenges and Lessons Learned - Deven Dandekar
12:15 - 12:45 | Round table: transgenic rodent models, where are we? What's next? What are the challenges? - All speakers

12:45 - 13:45 | Lunch Break - Exhibition area

13:45 - 14:15 | Sponsored Session: Charles River     
14:15 - 15:15 | AGA

15:15 - 15:45 | Afternoon Coffee Break - Exhibition area

15:45 - 16:15 | Award ceremony
16:16 - 17:00 | Genetically engineered pigs for translational biomedical research and toxicological assessment: The NHPig Consortium and beyond - Tatiana Flisikowska
17:00 - 17:45 | New Strategies for Generating Rabbit and Non-Human Primate Models of Human Disease Using Pluripotent Stem Cells - Pierre Savatier